Label: COVERGIRL OUTLAST EXTREME WEAR 3-IN-1 FOUNDATION 24 HR FULL COVERAGE SPF 18 OCTINOXATE SUNSCREEN LIQUID FOUNDATION- octinoxate emulsion

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated November 21, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredients

    Octinoxate 3.0%

  • Purpose

    Sunscreen

  • Uses

    • helps prevent sunburn
    • if used as directed with other sun protection measures

    (see Directions), decreases the risk of skin cancer and early aging caused by the sun.

  • Warnings

    Skin Cancer/Skin Aging Alert; ;Spending time inthesunincreasesyourriskofskincancerand earlyskinaging.Thisproducthasbeenshown only to help prevent sunburn, not skin cancer or early skin aging.

    For external use only.

  • Do not use

    • on damaged or broken skin.
  • When using this product

    • keep out of eyes. Rinse with water to remove.
  • Stop use and ask doctor if

    • rash occurs.
  • Keep out of reach of children.

    If swollowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • apply liberally 15 minutes before sun exposure
    • useawaterresistantsunscreenif swimming or sweating
    • reapply at least every 2 hours
    • children under 6 months of age: Ask a doctor
    • Sun Protection Measures.Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen witha Broad SpectrumSPF valueof 15 or higher and other sun protection measures including:
    • limit time in the sun,especially from 10 a.m.-2 p.m.
    • wear long-sleeved shirts, pants, hats, and sunglasses.
  • Other information

    • protect the product in this container from excessive heat and direct sun.
  • Inactive ingredients

    CYCLOPENTASILOXANE, AQUA/WATER/EAU, TALC, BUTYLENE GLYCOL, CETYL PEG/PPG-10/1 DIMETHICONE, ACRYLATES CROSSPOLYMER, TRIMETHYLSILOXYSILICATE, CETEARYL ETHYLHEXANOATE, DIMETHICONE/ VINYL DIMETHICONE CROSSPOLYMER, MAGNESIUM SULFATE, BIS-PEG/PPG-14/ 14 DIMETHICONE, AMMONIUM

    ACRYLATES COPOLYMER, TRIBEHENIN, DISTEARDIMONIUM HECTORITE, LAURETH-7, LECITHIN, TRIETHOXYCAPRYLYLSILANE, PHENOXYETHANOL, TRIHYDROXYSTEARIN, CHLORPHENESIN, PROPYLENE CARBONATE, ALCOHOL DENAT., DIMETHICONOL, XANTHAN GUM, GLYCERIN, DISODIUM EDTA, TOCOPHERYL ACETATE, DISODIUM DECETH-6 SULFOSUCCINATE, LAURETH-30, SODIUM PCA, UREA, SODIUM DEHYDROACETATE, TREHALOSE, HEXYLENE GLYCOL, POLYQUATERNIUM-51, BHT, CAPRYLYL GLYCOL, TRIACETIN, SODIUM HYALURONATE, PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE, [MAY CONTAIN/PEUT CONTENIR/+/-: IRON OXIDES (CI 77491, CI 77492, CI 77499), TITANIUM DIOXIDE (CI 77891)].

  • Questions or comments?

    Call 1-800-426-8374

  • Package Label

    Package Label

  • INGREDIENTS AND APPEARANCE
    COVERGIRL OUTLAST EXTREME WEAR 3-IN-1 FOUNDATION 24 HR FULL COVERAGE SPF 18 OCTINOXATE SUNSCREEN LIQUID FOUNDATION 
    octinoxate emulsion
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:22700-030
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE30 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    HEXYLENE GLYCOL (UNII: KEH0A3F75J)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    (4-NITROPHENYL)UREA (UNII: DY0F0348GL)  
    TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)  
    CETEARYL ETHYLHEXANOATE (UNII: 9M64UO4C25)  
    SODIUM HYALURONATE (UNII: YSE9PPT4TH)  
    LAURETH-30 (UNII: W9D845551A)  
    TREHALOSE (UNII: B8WCK70T7I)  
    BHT (UNII: 1P9D0Z171K)  
    CHLORPHENESIN (UNII: I670DAL4SZ)  
    SODIUM DEHYDROACETATE (UNII: 8W46YN971G)  
    SODIUM PCA (UNII: 469OTG57A2)  
    LAURETH-7 (UNII: Z95S6G8201)  
    TALC (UNII: 7SEV7J4R1U)  
    TRIBEHENIN (UNII: 8OC9U7TQZ0)  
    IRON OXIDES (UNII: 1K09F3G675)  
    TRIHYDROXYSTEARIN (UNII: 06YD7896S3)  
    DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
    MAGNESIUM SULFATE (UNII: DE08037SAB)  
    BIS-PEG/PPG-14/14 DIMETHICONE (UNII: X2I70H0QJE)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    TRIACETIN (UNII: XHX3C3X673)  
    PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE (UNII: 255PIF62MS)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    PROPYLENE CARBONATE (UNII: 8D08K3S51E)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    DISODIUM DECETH-6 SULFOSUCCINATE (UNII: SX9Q9F5YWB)  
    CYCLOPENTASILOXANE (UNII: 0THT5PCI0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:22700-030-011 in 1 CARTON12/01/2021
    130 mL in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02012/01/2021
    Labeler - Noxell Corporation (003082997)
    Establishment
    NameAddressID/FEIBusiness Operations
    Noxell Corporation003082997manufacture(22700-030)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!